M. Azria

2.0k total citations
38 papers, 1.5k citations indexed

About

M. Azria is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Oncology. According to data from OpenAlex, M. Azria has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Orthopedics and Sports Medicine, 16 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in M. Azria's work include Bone health and osteoporosis research (15 papers), Bone Metabolism and Diseases (15 papers) and Bone and Joint Diseases (6 papers). M. Azria is often cited by papers focused on Bone health and osteoporosis research (15 papers), Bone Metabolism and Diseases (15 papers) and Bone and Joint Diseases (6 papers). M. Azria collaborates with scholars based in Switzerland, United States and Belgium. M. Azria's co-authors include Linda Mindeholm, Stuart L. Silverman, Melvin Olson, Claus Christiansen, P. Burckhardt, D. Manicourt, Marc Engelhardt, C. H. Chesnut, M.A. Karsdal and Thierry Buclin and has published in prestigious journals such as Biochemical and Biophysical Research Communications, The American Journal of Medicine and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M. Azria

38 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Azria Switzerland 21 593 429 345 272 271 38 1.5k
Sara Peleg United States 27 592 1.0× 73 0.2× 310 0.9× 66 0.2× 23 0.1× 72 2.1k
Roman Skowroński United States 20 610 1.0× 51 0.1× 241 0.7× 81 0.3× 35 0.1× 46 2.0k
Mayu Morita Japan 19 398 0.7× 127 0.3× 153 0.4× 110 0.4× 94 0.3× 48 1.0k
Dan Liu China 21 413 0.7× 44 0.1× 140 0.4× 49 0.2× 128 0.5× 75 1.3k
Sunita Suri United Kingdom 8 263 0.4× 144 0.3× 198 0.6× 65 0.2× 504 1.9× 8 1.0k
Sadaf Ashraf United Kingdom 17 272 0.5× 109 0.3× 107 0.3× 142 0.5× 581 2.1× 25 1.3k
You‐Shuo Liu China 27 1.1k 1.9× 138 0.3× 78 0.2× 26 0.1× 72 0.3× 63 2.0k
Valentina Grishko United States 20 779 1.3× 46 0.1× 82 0.2× 54 0.2× 344 1.3× 26 1.6k

Countries citing papers authored by M. Azria

Since Specialization
Citations

This map shows the geographic impact of M. Azria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Azria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Azria more than expected).

Fields of papers citing papers by M. Azria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Azria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Azria. The network helps show where M. Azria may publish in the future.

Co-authorship network of co-authors of M. Azria

This figure shows the co-authorship network connecting the top 25 collaborators of M. Azria. A scholar is included among the top collaborators of M. Azria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Azria. M. Azria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rigel, Dean F., Bérengère Dumotier, David A. Sykes, et al.. (2019). Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived β2-Adrenoceptor Agonist with Functional Selectivity for Anabolic Effects on Skeletal Muscle Resulting in a Wider Cardiovascular Safety Window in Preclinical Studies. Journal of Pharmacology and Experimental Therapeutics. 369(2). 188–199. 15 indexed citations
2.
Mindeholm, Linda, Aino Launonen, Beate Kiese, et al.. (2012). The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women. Bone. 50(4). 965–973. 37 indexed citations
3.
Bay‐Jensen, Anne‐Christine, Rasmus Hjorth Nielsen, Toni Segovia‐Silvestre, et al.. (2011). A microarray analysis of full depth knee cartilage of ovariectomized rats. BMC Research Notes. 4(1). 63–63. 3 indexed citations
4.
Karsdal, M.A., Kim Henriksen, Anne‐Christine Bay‐Jensen, et al.. (2010). Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials. The Journal of Clinical Pharmacology. 51(4). 460–471. 77 indexed citations
5.
Karsdal, M.A., I. Byrjalsen, M. Azria, et al.. (2009). Influence of food intake on the bioavailability and efficacy of oral calcitonin. British Journal of Clinical Pharmacology. 67(4). 413–420. 33 indexed citations
6.
7.
Chesnut, C. H., M. Azria, Stuart L. Silverman, et al.. (2007). Salmon calcitonin: a review of current and future therapeutic indications. Osteoporosis International. 19(4). 479–491. 162 indexed citations
8.
Manicourt, D., M. Azria, Linda Mindeholm, Eugene J.‐M.A. Thonar, & Jean‐Pierre Devogelaer. (2006). Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis & Rheumatism. 54(10). 3205–3211. 107 indexed citations
9.
Bagger, Yu Z., László B. Tankó, Peter Alexandersen, et al.. (2005). Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: A new potential treatment of osteoarthritis. Bone. 37(3). 425–430. 87 indexed citations
10.
Azria, M.. (2002). Possible mechanisms of the analgesic action of calcitonin. Bone. 30(5). 80–83. 47 indexed citations
11.
Buclin, Thierry, et al.. (2002). Bioavailability and Biological Efficacy of a New Oral Formulation of Salmon Calcitonin in Healthy Volunteers. Journal of Bone and Mineral Research. 17(8). 1478–1485. 66 indexed citations
12.
Wallach, Stanley, et al.. (1999). Effects of calcitonin on animal and in vitro models of skeletal metabolism. Bone. 25(5). 509–516. 44 indexed citations
13.
14.
15.
Devogelaer, Jean‐Pierre, et al.. (1994). Comparison of the acute biological action of injectable salmon calcitonin and an injectable and oral calcitonin analogue. Calcified Tissue International. 55(1). 71–73. 11 indexed citations
16.
Feyen, Jean H.M., F. Cardinaux, R. Gamse, et al.. (1992). N-terminal truncation of salmon calcitonin leads to calcitonin antagonists. Biochemical and Biophysical Research Communications. 187(1). 8–13. 33 indexed citations
17.
Reginster, Jean‐Yves, et al.. (1992). Endogenous production of specific antibodies does not decrease hypocalcemic response to calcitonin in young rabbits. Calcified Tissue International. 50(6). 518–520. 10 indexed citations
18.
Reginster, Jean‐Yves, et al.. (1990). The effect of salmon calcitonin on blood-ionized calcium in the presence of anti-salmon calcitonin antibodies (from pagetic patients) in young rabbits. Open Repository and Bibliography (University of Liège). 7 indexed citations
19.
Lemaire, Michel, et al.. (1989). Disposition of sandostatin, a new synthetic somatostatin analogue, in rats.. Drug Metabolism and Disposition. 17(6). 699–703. 47 indexed citations
20.
Buclin, Thierry, et al.. (1987). The effect of rectal and nasal administration of salmon calcitonin in normal subjects. Calcified Tissue International. 41(5). 252–258. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Peleg Breakdown of academic impact, for papers by Roman Skowroński Breakdown of academic impact, for papers by Mayu Morita Breakdown of academic impact, for papers by Dan Liu Breakdown of academic impact, for papers by Sunita Suri Breakdown of academic impact, for papers by Sadaf Ashraf Breakdown of academic impact, for papers by You‐Shuo Liu Breakdown of academic impact, for papers by Valentina Grishko
Rankless by CCL
2026